Resverlogix: Top 10 Undervalued Nano Cap Stocks on TSX (RVX)
Resverlogix is now ranked among the top 10 nano cap stocks on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). Nano caps total market capitalization (<50M).
All data provided as-at market close March 16, 2023. The list is sorted by stocks with the greatest percentage difference between valuation and price. Resverlogix Resverlogix Corp is a clinical stage biotechnology company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer's & chronic kidney disease. Resverlogix is listed under RVX on the Toronto Stock Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| RVX-T | Resverlogix | 0.16 | 0 | 0 | 0 | 0 | 0 |
| IVQ-U-T | Invesque | 0.88 | 0 | 0 | 0 | 0 | 0 |
| ELEF-T | Silver Elephant Mining | 0.47 | 0 | 0 | 0 | 0 | 0 |
| DIAM-T | Star Diamond | 0.1 | 0 | 0 | 0 | 0 | 0 |
| BSX-T | Belo Sun Mining | 0.06 | 0 | 0 | 0 | 0 | 0 |
| VQS-T | VIQ Solutions | 0.41 | 0 | 0 | 0 | 0 | 0 |
| ADCO-T | Adcore | 0.26 | 0 | 0 | 0 | 0 | 0 |
| VIVO-T | VIVO Cannabis | 0.02 | 0 | 0 | 0 | 0 | 0 |
| FTU-T | US Financial 15 Split | 0.31 | 0 | 0 | 0 | 0 | 0 |
| WLLW-T | Willow Biosciences | 0.09 | 0 | 0 | 0 | 0 | 0 |
More about Resverlogix
Stocks in this category are held primarily for capital appreciation. Nano, micro, and small cap stocks can be very volatile and may generate high returns or losses. Whereas mid and large cap stocks tend to be more stable.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
